Search - tctmd.com

Displaying 241 - 260 of 2771

Sort: Relevancy | Date

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

News Conference News EHRA 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

April 16, 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

News Conference News EHRA 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

April 12, 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presentation Fellows 2024

The Role of Coronary Revascularization for Stable Ischemic Heart Disease

Presenter: Ajay J. Kirtane

April 12, 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

News Conference News EHRA 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

April 11, 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

CMR in Ischemic Cardiomyopathy

Presentation THT 2024

CMR in Ischemic Cardiomyopathy

Presenter: Jonathan Weinsaft

March 05, 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presentation THT Abstracts 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presenter: Eduardo Arias

March 04, 2024

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

News Daily News

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

February 28, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.